113 related articles for article (PubMed ID: 37850395)
21. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
Wang P; Chen S; Fang H; Wu X; Chen D; Peng L; Gao Z; Xie C
Oncotarget; 2016 Jan; 7(1):929-45. PubMed ID: 26498144
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-325-3p inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma by down-regulation of aquaporin 5.
Zhang Z; Han Y; Sun G; Liu X; Jia X; Yu X
Cell Mol Biol Lett; 2019; 24():13. PubMed ID: 30805015
[TBL] [Abstract][Full Text] [Related]
23. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma.
Hou J; Lin L; Zhou W; Wang Z; Ding G; Dong Q; Qin L; Wu X; Zheng Y; Yang Y; Tian W; Zhang Q; Wang C; Zhang Q; Zhuang SM; Zheng L; Liang A; Tao W; Cao X
Cancer Cell; 2011 Feb; 19(2):232-43. PubMed ID: 21316602
[TBL] [Abstract][Full Text] [Related]
24. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
Zhao X; Chen GQ; Cao GM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
[TBL] [Abstract][Full Text] [Related]
25. MiR-222-3p induced by hepatitis B virus promotes the proliferation and inhibits apoptosis in hepatocellular carcinoma by upregulating THBS1.
Sun Y; Shi P; Wu Q; Liu B; Yu Z; Jia H; Chang H
Hum Cell; 2021 Nov; 34(6):1788-1799. PubMed ID: 34273068
[TBL] [Abstract][Full Text] [Related]
26. Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism.
Cui ZH; Shen SQ; Chen ZB; Hu C
World J Gastroenterol; 2014 May; 20(18):5493-504. PubMed ID: 24833879
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA NRAV enhances proliferation and invasion of hepatocellular carcinoma cells by modulating the Wnt/β-catenin signaling pathway.
Wang Q; Tang Y; Ge Y; Zhang S; Zheng M
Bioengineered; 2022 Apr; 13(4):10026-10037. PubMed ID: 35436415
[TBL] [Abstract][Full Text] [Related]
28. Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma.
Wang W; Zhao LJ; Tan YX; Ren H; Qi ZT
World J Gastroenterol; 2012 Oct; 18(38):5442-53. PubMed ID: 23082062
[TBL] [Abstract][Full Text] [Related]
29. MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.
Liu L; Lu L; Zheng A; Xie J; Xue Q; Wang F; Wang X; Zhou H; Tong X; Li Y; Zhu X; Wu G
Oncotarget; 2017 Feb; 8(8):13666-13677. PubMed ID: 28099144
[TBL] [Abstract][Full Text] [Related]
30. Midazolam inhibits proliferation and accelerates apoptosis of hepatocellular carcinoma cells by elevating microRNA-124-3p and suppressing PIM-1.
Qi Y; Yao X; Du X
IUBMB Life; 2020 Mar; 72(3):452-464. PubMed ID: 31651086
[TBL] [Abstract][Full Text] [Related]
31. MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma.
Giovannini C; Fornari F; Dallo R; Gagliardi M; Nipoti E; Vasuri F; Coadă CA; Ravaioli M; Bolondi L; Gramantieri L
Acta Histochem; 2018 Feb; 120(2):95-102. PubMed ID: 29249451
[TBL] [Abstract][Full Text] [Related]
32. Dauricine upregulates the chemosensitivity of hepatocellular carcinoma cells: Role of repressing glycolysis via miR-199a:HK2/PKM2 modulation.
Li W; Qiu Y; Hao J; Zhao C; Deng X; Shu G
Food Chem Toxicol; 2018 Nov; 121():156-165. PubMed ID: 30171973
[TBL] [Abstract][Full Text] [Related]
33. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
Lin Z; Xia S; Liang Y; Ji L; Pan Y; Jiang S; Wan Z; Tao L; Chen J; Lin C; Liang X; Xu J; Cai X
Theranostics; 2020; 10(19):8834-8850. PubMed ID: 32754282
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-199a-3p inhibits tumorigenesis of hepatocellular carcinoma cells by targeting ZHX1/PUMA signal.
Guan J; Liu Z; Xiao M; Hao F; Wang C; Chen Y; Lu Y; Liang J
Am J Transl Res; 2017; 9(5):2457-2465. PubMed ID: 28559996
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720
[TBL] [Abstract][Full Text] [Related]
36. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
Shi Y; Yan F; Wang F; Pan L
Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of miR-362-3p Modulates Proliferation and Anchorage-Independent Growth by Directly Targeting Tob2 in Hepatocellular Carcinoma.
Shen H; Li W; Tian Y; Xu P; Wang H; Zhang J; Li Y
J Cell Biochem; 2015 Aug; 116(8):1563-73. PubMed ID: 25649327
[TBL] [Abstract][Full Text] [Related]
38. Upregulating microRNA-373-3p promotes apoptosis and inhibits metastasis of hepatocellular carcinoma cells.
Li H; Wang N; Xu Y; Chang X; Ke J; Yin J
Bioengineered; 2022 Jan; 13(1):1304-1319. PubMed ID: 34983307
[TBL] [Abstract][Full Text] [Related]
39. Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis.
Liu Y; Liu J; Cui J; Zhong R; Sun G
Bioengineered; 2022 Jan; 13(1):1115-1125. PubMed ID: 34978464
[TBL] [Abstract][Full Text] [Related]
40. MiR-490-3p inhibits autophagy via targeting ATG7 in hepatocellular carcinoma.
Ou Y; He J; Liu Y
IUBMB Life; 2018 Jun; 70(6):468-478. PubMed ID: 29676845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
